Will the health reforms proposed for the Labour Government make the system better or worse? Health commentator
Ian Powell (formerly the Executive Director of the Association of Salaried Medical Specialists) gives his analysis of what change is most necessary, and what should be avoided.
The review of the Health and Disability System by the Heather Simpson led panel (hereafter referred to as âSimpsonâ) is a review that needs to be rescued from itself. At the heart of this statement is the failure of Simpson to recognise how best to achieve sustainable transformational change beneficial to New Zealandâs universal health system. Pre-determination and deficient analysis are responsible for this failure.
A similar programme in Scotland was successful, returning £7.34 for every £1 spent after 10 years.
On Wednesday came a promise it ll happen. That project work is underway now, Ardern said. As I understand they re going through a procurement process, so I hope to see some progress on that fairly shortly.
But there s nothing when it comes to another key recommendation - Labour s election promise of increasing beneficiaries dental grants from $300 to $1000.
The Minister for Social Development Carmel Sepuloni says there s no real timeframe on delivery - just sometime this term . This term we will deliver on our manifesto commitment to increase dental health grants, ensuring those on low incomes are supported to cover the actual cost of dental care, Carmel Sepuloni, the Minister for Social Development and Employment, said in a statement.
(Originally published at The Democracy Project ) Will the health reforms proposed for the Labour Government make the system better or worse? Health commentator Ian Powell (formerly the Executive Director of the Association of Salaried Medical .
Staring down the barrel of a senior doctor staffing crisis livenews.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livenews.co.nz Daily Mail and Mail on Sunday newspapers.
New Zealand s medicinal cannabis supply in jeopardy
5 Feb, 2021 04:27 AM
6 minutes to read
NZ Herald
By: Kate MacNamara New Zealand is facing a collapse of legal medicinal cannabis supply after March 31st, when a deadline to meet stiff new government rules is expected to keep the products of three of the country s five main importers out of the market.
Last April, the Government unveiled a new regulatory system to create more safe, widespread and affordable access to medicinal cannabis, it has not yet approved a single product.
New Zealand-based importers Medleaf Therapeutics, Nubu Pharmaceuticals, and Eqalis Pharmaceuticals confirmed their products are not likely to be approved under the new standards before the March deadline. Domestic production, still in its very early stages, is not likely to reach the market until late this year.